Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Number of holders
-
14
-
Total shares
-
897K
-
Shares change
-
+22.7K
-
Total reported value, excl. options
-
$6.82M
-
Value change
-
+$173K
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$7.61
Significant Holders of Cryo-Cell International, Inc. - Common Stock, par value $0.01 per share (CCEL) as of Q2 2024
filings reported holding CCEL - Cryo-Cell International, Inc. - Common Stock, par value $0.01 per share as of Q2 2024.
Cryo-Cell International, Inc. - Common Stock, par value $0.01 per share (CCEL) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 897K shares
.
Largest 10 shareholders include HAMILTON LANE ADVISORS LLC (410K shares), SFI Advisors, LLC (165K shares), VANGUARD GROUP INC (115K shares), MASSMUTUAL TRUST CO FSB/ADV (111K shares), GEODE CAPITAL MANAGEMENT, LLC (23.7K shares), NORTHERN TRUST CORP (22.2K shares), Cerity Partners LLC (19.6K shares), ROWLANDMILLER & PARTNERS.ADV (14.4K shares), BlackRock Inc. (13.1K shares), and OSAIC HOLDINGS, INC. (2K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.